Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

Similar articles for PubMed (Select 21415953)

1.

Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients.

Marzano A, Marengo A, di Fonzo M, Begini P, Ferrari A, Monarca B, Delle Fave G, Marignani M.

Mediterr J Hematol Infect Dis. 2010 Dec 13;2(1):e2010035. doi: 10.4084/MJHID.2010.035.

2.

E-OncoHealth: telemedicine program for monitoring onco-hematological outpatients.

Escudero-Vilaplana V, Ribed A, Ibáñez-García S, Collado-Borrell R, Anglada-Martínez H, Herranz-Alonso A, Codina-Jané C, Sanjurjo-Sáez M.

Stud Health Technol Inform. 2015;210:960-1. No abstract available.

PMID:
25991314
3.

[Clinical characteristics of hepatitis E virus infection in patients with hematological malignancies].

Yuan X, Li X, Zhu Z, Zhang Y, Jiang L, Ma R, Lei P, Chen Y, Bai Y.

Zhonghua Xue Ye Xue Za Zhi. 2015 Mar;36(3):247-9. doi: 10.3760/cma.j.issn.0253-2727.2015.03.018. Chinese. No abstract available.

4.

Multidrug-resistant bacteria and bloodstream infections in onco-hematological patients.

Tumbarello M, Micozzi A, De Rosa FG.

J Chemother. 2014 Sep 25:1973947814Y0000000216. [Epub ahead of print] No abstract available.

PMID:
25257205
5.

Two cases of paralitic ileus in onco-hematologic patients.

Carraro F, Rivetti E, Romano E, Fagioli F.

Pediatr Rep. 2012 Jan 2;4(1):e3. doi: 10.4081/pr.2012.e3. Epub 2012 Jan 17.

6.

Patients with hematological malignancies and serological signs of prior resolved hepatitis B.

Marignani M, Gigante E, Begini P, Marzano A, di Fonzo M, Deli I, Gallina S, Cox MC, Delle Fave G.

World J Gastrointest Oncol. 2012 Mar 15;4(3):37-45. doi: 10.4251/wjgo.v4.i3.37.

7.

[Immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection].

Sato K.

Gan To Kagaku Ryoho. 2011 Feb;38(2):161-8. Review. Japanese.

PMID:
21368477
8.

The difficulties of managing severe hepatitis B virus reactivation.

Roche B, Samuel D.

Liver Int. 2011 Jan;31 Suppl 1:104-10. doi: 10.1111/j.1478-3231.2010.02396.x. Review.

PMID:
21205146
9.

HBV disease: HBsAg carrier and occult B infection reactivation in haematological setting.

Marinone C, Mestriner M.

Dig Liver Dis. 2011 Jan;43 Suppl 1:S49-56. doi: 10.1016/S1590-8658(10)60692-5.

PMID:
21195372
10.

[The effect of antiviral therapy for patients with HBeAg-negative cirrhosis].

Jie YS, Chen LB, Shu X, Yang XA, Zhang K, Xu QH, Li G.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010 Feb;24(1):45-7. Chinese.

PMID:
20848849
11.

Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management.

Lubel JS, Angus PW.

J Gastroenterol Hepatol. 2010 May;25(5):864-71. doi: 10.1111/j.1440-1746.2010.06243.x. Review.

PMID:
20546439
12.

Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.

Ji D, Cao J, Hong X, Li J, Wang J, Chen F, Wang C, Zou S.

Eur J Haematol. 2010 Sep;85(3):243-50. doi: 10.1111/j.1600-0609.2010.01474.x. Epub 2010 May 20.

PMID:
20491883
13.

Living donor liver transplantation for acute hepatic failure caused by reactivation of hepatitis B virus infection after chemotherapy for hematologic malignancy: case reports.

Kim SG, Chun JM, Jin R, Kim JY, Won DI, Hwang YJ.

Transplant Proc. 2010 Apr;42(3):843-5. doi: 10.1016/j.transproceed.2010.02.038.

PMID:
20430187
14.

[Fulminant hepatic failure with hepatitis B virus reactivation after rituximab treatment in a patient with resolved hepatitis B].

Chung SM, Sohn JH, Kim TY, Yoo KD, Ahn YW, Bae JH, Jeon YC, Choi JH.

Korean J Gastroenterol. 2010 Apr;55(4):266-9. Korean.

15.

[Hepatitis B virus and chronic progressive kidney disease].

Kes P, Slavicek J.

Acta Med Croatica. 2009 Dec;63(5):397-402. Croatian.

PMID:
20198898
16.

Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.

Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A.

Biol Blood Marrow Transplant. 2010 Jun;16(6):809-17. doi: 10.1016/j.bbmt.2009.12.533. Epub 2010 Jan 7.

17.

Management of hepatitis B virus reactivation in patients with hematological malignancies treated with chemotherapy.

Francisci D, Falcinelli F, Schiaroli E, Capponi M, Belfiori B, Flenghi L, Baldelli F.

Infection. 2010 Feb;38(1):58-61. doi: 10.1007/s15010-009-9019-1. Epub 2009 Nov 10.

PMID:
19904491
18.
19.

[Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients].

Fan LY, Zhou Z, Zhong S, Ling N, Wang ZY, Shi XF, Zhang DZ, Ren H.

Zhonghua Gan Zang Bing Za Zhi. 2009 Jun;17(6):429-33. Chinese.

PMID:
19567021
20.

Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier.

Fukushima N, Mizuta T, Tanaka M, Yokoo M, Ide M, Hisatomi T, Kuwahara N, Tomimasu R, Tsuneyoshi N, Funai N, Sueoka E.

Ann Oncol. 2009 Dec;20(12):2013-7. doi: 10.1093/annonc/mdp230. Epub 2009 Jun 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk